Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHRS | ACIU | RENB | ||
| Company | Coherus Bio | AC Immune S.A. | Renovaro Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.96 | 2.30 | 1.7900 | ||
| High | 2.06 | 2.50 | 2.1000 | ||
| Low | 1.93 | 2.25 | 1.5000 | ||
| Last | 2.04 | 2.35 | 1.5300 | ||
| Change | +0.11 | +0.06 | -0.1700 | ||
| % Change | +5.70% | +2.62% | -10.00% | ||
| Volume | 907,100 | 107,700 | 1,044,300 | ||
| 20-Day Average Volume | 1,695,250 | 236,710 | 246,090 | ||
| Previous Close | 1.93 | 2.29 | 1.7000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.24 | 2.58 | 2.4000 | ||
| 20-Day Raw Stochastic | 18.57% | 12.99% | 1.94% | ||
| 20-Day Relative Strength | 42.68% | 35.11% | 30.98% | ||
| Weighted Alpha | -62.92 | -23.43 | -38.33 | ||
| Today's Opinion | 100% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 24% Sell | 24% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.45% since 04/19/24 | -0.42% since 04/19/24 | -29.49% since 04/19/24 | ||
| Low | 1.91 on 04/25/24 | 2.25 on 04/26/24 | 1.5000 on 04/26/24 | ||
| High | 2.24 on 04/23/24 | 2.51 on 04/23/24 | 2.2000 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | -11.30% since 03/26/24 | -17.25% since 03/26/24 | -47.60% since 03/26/24 | ||
| Low | 1.91 on 04/25/24 | 2.25 on 04/26/24 | 1.5000 on 04/26/24 | ||
| High | 2.61 on 04/09/24 | 3.18 on 03/28/24 | 3.0500 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -12.82% since 01/26/24 | -33.24% since 01/26/24 | -67.10% since 01/26/24 | ||
| Low | 1.91 on 04/25/24 | 2.25 on 04/26/24 | 1.5000 on 04/26/24 | ||
| High | 2.87 on 02/15/24 | 4.08 on 02/28/24 | 4.8800 on 01/29/24 | ||
| 6-Month | |||||
| %Chg | -25.55% since 10/26/23 | -18.97% since 10/26/23 | -45.36% since 10/26/23 | ||
| Low | 1.43 on 11/10/23 | 2.25 on 04/26/24 | 1.5000 on 04/26/24 | ||
| High | 3.73 on 11/06/23 | 5.14 on 12/28/23 | 5.2500 on 01/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 231,536 | 232,413 | 219,812 | ||
| Shares Outstanding, K | 113,498 | 98,899 | 143,668 | ||
| Annual Sales | 257,240,000 | 16,490,000 | 0 | ||
| Annual Net Income | -237,890,000 | -60,410,000 | -39,680,000 | ||
| Last Quarter Sales | 91,520,000 | 16,710,000 | 0 | ||
| Last Quarter Net Income | -79,650,000 | -5,620,000 | -4,530,000 | ||
| 60-Month Beta | 0.54 | 1.00 | 0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 03/13/24 | -0.06 on 03/14/24 | -0.07 on 02/14/24 | ||
| Latest Earnings Date | 05/13/24 | 04/26/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||